Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.

Proceedings of the National Academy of Sciences of the United States of America
K SakaiL Steinman

Abstract

Two synthetic immunodominant and nonencephalitogenic peptides of myelin basic protein, N1-20 and AcN9-20, effectively compete with an encephalitogenic peptide, AcN1-11, in an in vitro T-cell response restricted by class II major histocompatibility complex products (I-Au). These mutant peptide constructs, which do not occur in nature, also compete with the self-antigen for the in vivo induction of T cells primed with the encephalitogen AcN1-11. By using these nonpathogenic competitor peptides, it is possible to prevent the development of a prototypic T-cell-mediated autoimmune disease, experimental allergic encephalomyelitis. These results suggest possibilities for the utilization of competitor peptides for therapy of T-cell-mediated autoimmune diseases linked to specific major histocompatibility complex genes.

References

Feb 20, 1987·Science·J G GuilletM L Gefter
Jan 15, 1988·The Journal of Immunology : Official Journal of the American Association of Immunologists·P J Higgins, H L Weiner
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·K SakaiL Steinman
Dec 1, 1988·The Journal of Experimental Medicine·L AdoriniZ A Nagy

❮ Previous
Next ❯

Citations

Dec 1, 1993·Diabetes/metabolism Reviews·C G Fathman
Jan 1, 1991·Molecular Aspects of Medicine·D WestmacottA D Sedgwick
Feb 1, 1991·Current Opinion in Immunology·S C Smith, P M Allen
Dec 1, 1992·Current Opinion in Biotechnology·H WaldmannJ Isaacs
Jan 1, 1996·Disease-a-month : DM·S G Lynch, J W Rose
Jan 29, 1999·Research in Immunology·V K Kuchroo, H L Weiner
Oct 6, 2007·Nature Reviews. Immunology·Alan G Baxter
Apr 29, 1998·Immunology and Cell Biology·D O Willenborg, M A Staykova
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D R MilichJ E Jones
Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D E SmilekH O McDevitt
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y Katz-LevyE Mozes
Sep 1, 1991·The Journal of Experimental Medicine·H YsselG Peltz
Dec 1, 1990·Immunological Reviews·D E SmilekH O McDevitt
Jan 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J M PenningerK Bachmaier
Dec 30, 1991·Annals of the New York Academy of Sciences·L Steinman
Jun 21, 1993·Annals of the New York Academy of Sciences·L MoiolaB M Conti-Tronconi
Oct 11, 1992·The Journal of Clinical Investigation·M P ProttiB M Conti-Tronconi
Dec 11, 2013·Clinical & Developmental Immunology·Masha Fridkis-Hareli
Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·L B NicholsonV K Kuchroo
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y Katz-LevyE Mozes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.